skip to main content

brainstorm askiatroX medicines

simulations beta

loading page…

learn & practise

exams international doctors free questions Socratic Tutor rounds stat clinical connections academy journal tool guides

clinical reference

askiatroX knowledge centre medicines UK / NICE guidance international guidance calculators q&a library

trust & support

how it works methodology account & support frequently asked questions about us clinical safety consultancy

legal

mobile app · scan to download

Medicines Recombinant crisantaspaseQuestion & answer

Recombinant crisantaspase · Medicine question

Can it treat both leukaemia and lymphoma?

iatroX medicinesPublished 18 August 2026Reviewed 18 August 2026

The answer

Answer

Yes. Its licence covers acute lymphoblastic leukaemia and lymphoblastic lymphoma in the specified asparaginase-replacement setting.

Sources for this answer

Enrylaze 10 mg/0.5 ml Solution for injection/infusionemc · SmPC Current selected SmPC · Version 2

Explore this learning need in CPDTake this topic to CPD, then choose your learning context and available question library.

The full medicine guide

Recombinant crisantaspase

Read the wider context, including uses, precautions and the sources behind this medicine guide.

Read the Recombinant crisantaspase guide

More questions about Recombinant crisantaspase

Why is it used after another asparaginase?Is it chemotherapy?Can children receive it?Is it given into a vein or muscle?Can it be administered at home?Can it still cause an allergy after an E. coli asparaginase allergy?

More clinical questions?

Explore the tools and reference material available on iatroX.

Explore askiatroX